3D printed fibroblast-loaded hydrogel for scleral remodeling to prevent progression of myopia

Jingwen Hui,Xiongfeng Nie,Pinghui Wei,Jie Deng,Yuanzhe Kang,Kexin Tang,Guoge Han,Ling Wang,Wenguang Liu,Quanhong Han
DOI: https://doi.org/10.1039/d3tb02548a
IF: 7.571
2024-02-02
Journal of Materials Chemistry B
Abstract:Pathologic myopia has seriously jeopardized the visual health of adolescents in the past decades. The progression of high myopia is associated with a decrease in collagen aggregation and thinning of the sclera, which ultimately leads to longer eye axis lengths and image formation in front of the retina. Here, we report a fibroblasts-loaded hydrogel as a posterior scleral reinforcement (PSR) surgery implant for prevention of myopia progression. Fibroblasts-loaded gelatin methacrylate (GelMA) - poly(ethylene glycol) diacrylate (PEGDA) hydrogel was prepared through bioprinting of digital light processing (DLP). The introduction of the PEGDA component endowed the GelMA-PEGDA hydrogel with higher compression modulus for PRS surgery. Encapsulated fibroblasts consistently maintain a high survival rate during 7-days in vitro incubation, and can normally secrete type I collagen. Eventually, both hydrogel and fibroblasts-loaded hydrogel demonstrated effective shortening of myopic eye axis length in a guinea pig model of visual deprivation over three weeks after implantation, and the sclera thickness of myopic guinea pigs became significantly thicker after 4 weeks, which proved the success of sclera remodeling and myopic progression was effectively controlled. In particular, the fibroblasts-loaded hydrogel had the best therapeutic effect due to the synergistic effect of cell therapy and PSR surgery.
materials science, biomaterials
What problem does this paper attempt to address?